- Research
- Open access
- Published:
Trends and delays in pulmonary tuberculosis diagnosis among elderly patients (≥ 60 Years) in Southern China: a 13-year surveillance data analysis (2010–2022)
BMC Public Health volume 25, Article number: 1854 (2025)
Abstract
Background
The prevalence of delays in receiving effective tuberculosis (TB) prevention and control measures is notably high, particularly among elderly patients. This study aims to explore the trends in diagnostic delays and assess the factors associated with these delays among elderly pulmonary tuberculosis (PTB) patients in Guangdong Province, Southern China.
Methods
We analyzed surveillance data from the Tuberculosis Information Management System (TBIMS), covering pulmonary tuberculosis cases in Guangdong Province from 2010 to 2022. We categorized patient delay (PD), health system delay (HSD), and total diagnostic delay (TDD) among patients aged 60 years and older. Trends in annual delays were examined using a Joinpoint regression program. Both univariate and multivariate logistic regression analyses were conducted to identify factors influencing TDD.
Results
The study found that the notification rate of PTB among elderly patients decreased from 155.85 per 100,000 in 2010 to 71.15 per 100,000 in 2022. However, the proportion of elderly patients among newly diagnosed TB cases increased from 20.66% to 30.37%. The median PD decreased from 29 days to 21 days, while the median HSD increased from 0 days to 3 days. Consequently, the TDD remained stable at 32 days. The average delay rates for PD, HSD, and TDD were 64.80%, 13.90%, and 75.80%, respectively. Joinpoint regression analysis showed a decreasing trend in PD rate and an increasing trend in HSD rate among patients aged ≥ 60 years, but no statistically significant change in TDD rate was observed. Significant risk factors for higher TDD included being a farmer, first visit to non-designated facilities, initial diagnosis at county-level hospitals, passive case finding, residence in underdeveloped areas, and respiratory comorbidities.
Conclusions
The burden and delays associated with TB diagnosis remain significant among the elderly in Southern China. Enhanced health education and proactive screening efforts are crucial for this high-risk group to mitigate diagnostic delays, particularly for those with respiratory comorbidities and in less developed regions. Future research should focus on addressing these barriers and evaluating the effectiveness of tailored interventions to improve TB control strategies for the elderly.
Introduction
Tuberculosis (TB) continues to pose a severe threat to global public health, having reclaimed its position as the leading cause of death worldwide from a single infectious agent, surpassing human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS), highlighting the urgent need for effective control measures [1]. Among high-risk groups, the elderly population is particularly vulnerable, facing a disproportionate burden of TB, especially in the Western Pacific region [2]. This vulnerability is exacerbated by the aging population, a trend that is notably pronounced in countries like China.
China ranks the third highest burden country globally in new TB cases, contributing approximately 6.8% [1]. This substantial impact is further compounded by the country’s rapidly aging population. This demographic shift presents a unique challenge, as the elderly are more susceptible to TB due to their weakened immune systems and the presence of multiple comorbidities [3, 4]. The intersection of these two factors—an aging population and a high TB burden—necessitates a focused examination of TB control measures tailored to the elderly.
Previous studies have highlighted that China’s aging population significantly impacts TB control efforts, with the elderly being particularly susceptible to the disease [5, 6]. The importance of early and timely diagnosis in reducing TB incidence has been emphasized, and the experience of countries like Japan demonstrates the significant impact of elderly TB control on national TB programs [7, 8]. Conversely, diagnostic delay can exacerbate disease progression, worsen clinical outcomes, and facilitate TB transmission within the community [9]. However, despite these insights, there remains a gap in the systematic interpretation of all stages of diagnostic delay specifically among the elderly.
This gap is particularly pronounced in regions like Guangdong, which bears the heaviest TB burden in China [10, 11]. The need for region-specific data is critical, as it can inform tailored interventions and control measures. Delays in diagnosis and treatment among the elderly in Guangdong may exacerbate the TB burden, highlighting the urgent need for focused research in this area [12].
The present study aims to address this gap by analyzing the trends of pulmonary tuberculosis (PTB) with Patient Delay (PD), Health System Delay (HSD), and Total Diagnostic Delay (TDD) in Southern China from 2010 to 2022. Utilizing 13 years of surveillance data, this study seeks to provide a comprehensive analysis of diagnostic delay patterns and their determinants among elderly PTB patients aged 60 years and above. By applying rigorous statistical methods, the study will examine trends and correlations to identify associations between influencing factors and TDD. These findings will be instrumental in formulating recommendations for improving TB diagnosis and control measures tailored to the elderly population in Guangdong. By addressing the specific challenges faced by this demographic, the study aims to contribute to the broader goal of reducing TB incidence and improving public health outcomes in China.
Materials and methods
Regions involved in this study
Guangdong, located in the Southern China, is the most economically developed province with a permanent population of 126.57 million in 2022 [13]. It comprises of 21 prefecture-level cities and nine of them in the central area make up a more developed area known as the Pearl River Delta region (PRDR) and other cities make up underdeveloped areas including the Eastern Guangdong (EG), Western Guangdong (WG) and Northern Guangdong (NG) (Fig. 1). The level of economic development in Guangdong presents a regional imbalance, where the GDP per capita in PDR is eight times higher than EG, WG and NG [13]. The number of elderly population aged 60 years and above was over 1.7 million in the end of 2022, which accounts for 13.45% of the total population [13].
PRDR consists of 9 cities including Guangzhou (GZ), Shenzhen (SZ), Foshan (FS), Dongguan (DG), Huizhou (HZ), Zhongshan (ZS), Zhuhai (ZH), Jiangmen (JM) and Zhaoqing (ZQ). EG consists of Shantou (ST), Shanwei (SW), Jieyang (JY) and Chaozhou (CZ).WG consists of Zhanjiang (ZJ), Maoming (MM), Yangjiang (YJ) and Yunfu (YF). NG consists of Meizhou (MZ), Heyuan (HY), Qingyuan (QY) and Shaoguan (SG).
Data source and collection
Data source
Data was extracted from the Tuberculosis Information Management System (TBIMS) [14], which was a comprehensive, nationwide and internet-based system. The TBIMS collected socio-demographic and clinical information at the time of patients’ registration and during management. The demographic information included age, gender, ethnicity, occupation, residence, and vulnerability status. The clinical information included the following aspects: institutional category of the first medical visit (designated TB care facilities/non-designated facilities), hospital levels of initial diagnosis (provincial and prefecture-level/county-level), methods of case finding (active/passive), time of case finding (before COVID-19/during COVID-19), region of case finding (developed area/underdeveloped area), etiological diagnosis (positive/negative), treatment category (new/retreated), HIV/AIDS (yes/no), diabetes mellitus (DM) (yes/no), and respiratory comorbidities (yes/no). The other important dates registered included date of symptom onset, first doctor visit, diagnosis, registration, treatment initiation and end.
Inclusion and exclusion criteria
PTB cases were included if they met the following criteria(Fig. 2):
Inclusion criteria:
- Confirmed or clinically diagnosed PTB according to WS288-2008/2017 guidelines.
Exclusion criteria:
-Nontuberculous mycobacteria(NTM) (n = 837);
-Extrapulmonary TB (n = 1,827);
-Outliers (Interval from onset to confirmation of PTB was less than 0 or more than 10 years, n = 5,962);
-Missing variables (n = 216);
- Aged < 60 years at diagnosis(n = 594,302).
Definitions
In China, PTB cases were identified using the national diagnostic criteria for PTB (WS288-2008 and WS288-2017) and the classification for TB (WS196-2001 and WS196-2017). All reported PTB cases encompassed both laboratory-confirmed and clinically diagnosed cases. Laboratory confirmation of PTB was established through bacteriological evidence obtained from sputum smear, sputum culture, or eligible rapid diagnostic technology. Clinically diagnosed PTB was characterised by clinical symptoms, chest imaging, epidemiological evidence, and immunological results.
We adopted the framework of time delay by the WHO [15]. Within this framework, PD refers to the period from symptom onset to the first medical consultation, while HSD pertains to the period from the first medical consultation to the diagnosis of TB [4]. TDD encompasses the time from the onset of symptoms to TB diagnosis. The conceptual framework on definitions of delay was displayed in S1 Fig. The cut-off point for analysing PD and HSD was set at 14 days, and for TDD was set at 28 days, meaning that values above the cut-off point were defined as delays. The set standard for PD/HSD (14 days) and TDD (28 days) was aligned with studies in high-burden settings [16, 17]. The delay rate is calculated as the annual number of individuals experiencing delay, divided by the total number of individuals.
Statistical analysis
Descriptive analysis
Demographic data was analysed descriptively using R software (version 4.3.2, R Foundation for Statistical Computing). Continuous variables were presented as median and interquartile ranges (IQR), while categorical variables were expressed as count and percentages. Mantel-Haenszel χ2 test was used to analyze the annual trend.
Time trend analysis
To calculate the annual percent change (APC) in the delay rate of PTB and identify a trend, we used Joinpoint software (Joinpoint Regression Program, Version 5.0; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute). APCs represented changes within a specific period. An “increasing or decreasing” trend was defined if APC significantly differed from zero (APC > 0: an increasing trend; APC < 0: a decreasing trend). If not, the trend was defined as “stable”. By dividing the study period into various intervals, the Joinpoint regression method optimises the trend for each interval, thereby providing a detailed evaluation of interval-specific disease characteristics [18]. The trend over the entire time series can be summarized using the average annual percent change (AAPC), calculated as the weighted average of the APCs. The model identifies statistically significant turning points and calculates the corresponding t-value and P-value through Monte Carlo permutation testing. It then selects the best-fit models based on the Bayesian information criterion. In this study, the dependent variables were PD rate, HSD rate, and TDD rate per year, while the independent variable was time (the year of patients’ notification). A statistically significant trend change in this time segment was indicated when the APC or AAPC had a P < 0.05 and the 95% confidence intervals (CI) did not include 0.
Analysis on influence factors of TDD
To identify the factors affecting TDD among elderly patients, univariate and multivariate logistic regression analyses were conducted with crude and adjusted odds ratios (cOR and aOR) and 95% CI, respectively. A P-value of less than 0.05 was considered statistically significant.
Results
Notification numbers and rates of PTB patients
In total, 791,030 TB cases were recorded in Guangdong Province from 2010 to 2022. According to the inclusion and exclusion criteria, consequently 187,886 patients aged 60 years and above were included in the present study. The notification rate for this age group decreased from 155.85 per 100,000 in 2010 to 71.15 per 100,000 in 2022, with an annual decline rate of 6.33% (χ² = 8157.48, P < 0.001). The percentage of newly diagnosed TB patients aged 60 years and above increased from 20.66% in 2010 to 30.37% in 2022, with an annual growth rate of 3.26% (χ² =3827.89, P < 0.001) (Table 1).
Interval days and delay rates of PTB patients
The median and IQR of PD, HSD and TDD from 2010 to 2022 among patients aged 60 years and above were 27 (8–61) days, 1 (0–6) days and 32 (15–68) days, respectively. The interval days of PD decreased from 29 (9–62) in 2010 to 21 (6–56) in 2022, while the interval days of HSD increased from 0 (0–3) to 3 (0–12). And the interval days of TDD remained stable at 32 days. The average delay rates of PD, HSD, and TDD from 2010 to 2022 were 64.80%, 13.90%, and 75.80%, respectively. The delay rate of PD decreased from 66.08% in 2010 to 59.09% in 2022, while the delay rate of HSD increased from 8.42% to 21.47%. The delay rate of TDD showed a slight increase from 73.76% in 2010 to 75.06% in 2022. Details are shown in Table 2.
Time trends of delay rate
Joinpoint regression analysis revealed a downward trend of PD rate among patients aged 60 years and above from 2010 to 2022, with AAPC of -0.73% (95% CI, -1.37 to-0.14) and from 2014 to 2022 with an annual percent change (APC) of -1.55% (95% CI, -4.29 to-1.02). Upward trends in HSD rate were observed with the AAPC of 8.63% (95% CI, 7.77 to 9.29), and from 2010 to 2015 with an APC of 6.46% (95% CI, 2.06 to 8.33) and from 2015 to 2019 with an APC of 15.16% (95% CI, 12.21 to 19.15). However, no statistically significant change in TDD rate was found among patients aged 60 years and above from 2010 to 2022, remaining around 75.80%. Additional details are displayed in Table 3 and S2 Fig.
Influencing factors of TDD
Univariate and multivariate logistic regression analyses were performed to identify significant variables influencing TDD (0 = no, 1 = yes). Higher TDD was observed in farmers (aOR: 1.12, 95% CI: 1.09–1.15), patients visiting non-designated facilities for their first doctor visit (aOR: 1.18, 95% CI: 1.10–1.26), patients receiving initial diagnosis at county-level hospitals (aOR: 1.06, 95% CI: 1.03–1.09), patients identified through passive finding methods (aOR: 1.07, 95% CI: 1.05–1.10), patient located in underdeveloped area (aOR: 1.41, 95% CI: 1.38–1.44), and patients with respiratory comorbidities (aOR: 1.86, 95% CI: 1.74–1.99) were identified as risk factors for higher TDD in PTB patients aged 60 years and above. Conversely, being male (aOR:0.95, 95% CI:0.93–0.98) was considered a protective factor with a lower TDD rate of 75.7%, as presented in Fig. 3 and S1 Table.
Forest plot of the influencing factors analysis for TDD among patients aged ≥ 60 years. *vulnerability status was defined as being a close contact of active PTB patients, working in healthcare or school/daycare settings, serving as a supervisor in prisons or detention centers, working in animal husbandry, being a dust collector or having pneumoconiosis, having a psychiatric disorder, residing in nursing or welfare facilities, or living in other crowded environments. #Region of case finding included developed area (PRDR) and underdeveloped area (EG, WG and NG)
Discussion
To the best of our knowledge, this study is pioneering in its investigation of diagnostic delay among the elderly patients aged 60 years and above in China. It yields three crucial findings. Firstly, while the notification rate of patients aged 60 years and above decreased, the proportion of these patients among newly diagnosed TB cases increased annually. Secondly, there was a decrease in both the number of days and the rates of PD among this demographic, whereas the number of days and rates of HSD increased, resulting in a relatively stable trend in the TDD. Thirdly, elderly patients with respiratory comorbidities have higher risk of TDD, particularly in underdeveloped areas, exhibited a higher risk of TDD. Given the global rise in elderly populations, the insights from this study could inform TB control policies, especially in underdeveloped regions or areas with constrained health resources.
Projections indicate that the proportion of individuals aged 60 and above in China could increase from 12.4% (168 million) in 2010 to 28.0% (402 million) by 2040 [19]. Recent studies indicate that TB notification rates increase with age globally [20, 21]. Similar results were observed in our study, with an increasing proportion of elderly individuals among the total notified PTB cases. On one hand, factors such as gradual immune deterioration, malnutrition, poverty, reduced access to health services, and comorbidities likely contribute to the heightened TB risk in aging populations [4, 16]. On the other hand, it is estimated that 90% of TB cases in the elderlies result from the reactivation of latent TB infection acquired earlier in life, rather than recent transmission [22]. The snowballing effect of accumulated long-term latent TB reactivation may result in a substantial increase in the burden among elderly PTB patients. According to China’s Fifth National Prevalence Survey of Tuberculosis, a substantial portion of the elderly were asymptomatic, with 53.2% opting not to seek medical care [23], underscoring the urgent needs to address PTB among these populations.
Our findings revealed a median of TDD of 32 days with a relatively stable trend among patients aged 60 years and above. Within China, the PD of elderly patients in Guangdong (21–29 days) was longer than Zhejiang (3–17 days) [9], likely reflecting regional disparities in healthcare access. The median HSD in Guangdong (3 days) was shorter than India (5.57–11.44 days) [24]. Since 2011, China’s new service delivery model, which shifted TB diagnosis and treatment from CDCs to designated TB care facilities, has improved TB diagnosis timeliness [25]. However, our data show contradictory trends between PD and HSD. The decrease in PD might suggest some success in public health campaigns aimed at raising awareness and reducing barriers to healthcare access among elderly populations. More importantly, the increase in HSD highlights significant shortcomings within the healthcare system itself. The rising HSD contrasts with global declines attributed to molecular diagnostics [26], highlighting systemic gaps in Guangdong. Firstly, uneven adoption of Xpert MTB/RIF in underdeveloped areas delayed testing [7]. Secondly, overcrowded county hospitals prioritized acute care over TB screening [7]. Finally, Elderly patients often first visit non-designated institutions (aOR = 1.18), where clinicians may lack TB awareness, leading to delayed referrals [12]. This divergence highlights systemic inefficiencies masked by improved patient awareness, a finding not previously emphasized in similar contexts. Thus, it is essential to explore the key factors affecting TB diagnosis delays in elderly patients.
Considering the practical significance of influencing factors, this study focused on indicators with aOR values more than 1.2 or less than 0.9. In accordance with other studies [27], respiratory comorbidities were significantly associated with TDD. The challenging mainly due to less frequently classical symptoms and similarities between TB symptoms and those of other respiratory conditions, such as cough [28]. This overlap can reduce clinicians’ alertness to TB, accompanied with lacking of efficient diagnostic tools for early detection [29]. A study in Bangladesh showed that 31% patients with cough were misdiagnosed as having a common cold without further TB related examination [30]. Furthermore, the clinical symptoms and radiographic findings of PTB in elderly individuals tend to be nonspecific, merging with decreased access to health services, further complicating timely TB diagnosis due to atypical manifestations [31].
Regarding the region of case finding, our study found that the TDD was more common in underdeveloped areas. This might attribute to two factors including economic development of areas and the capacity of local medical facilities. The proportion of rural residents in in EG, WG and NG is higher than that in PRDR, which was an important determinant of patient delay in seeking and receiving care for TB. A Previous review showed that lower-income individuals were less likely to seek care for TB than those with higher incomes [4]. Patients in rural areas or low-resource areas often face barriers to accessing TB services due to economic constrains or far distance from medical facilities [5]. As noted by Zhang et al. [7], the inadequacy of TB laboratory equipment in low-level healthcare facilities and a lack of TB awareness among clinicians further exacerbate these challenges. If the patients making their first doctor visit in these facilities in underdeveloped areas, they would be unable to obtain timely screening and diagnosis of TB. Immediate TB testing at the first visit could reduce diagnostic delays, as demonstrated by a modelling study in India [24]. In summary, enhancing health awareness among the elderly and improving the service capacity and quality of health facilities are crucial measures to address these issues.
This study had several notable limitations that should be acknowledged. First, we only studied TB patients in a southern province of China, which may not be representative of patients nationwide. Secondly, our data were derived from TBIMS, which lacks information such as education, economic status, marital status, medical insurance, and TB knowledge. Future studies could supplement surveillance data with patient interviews including these characteristics to enhance accuracy. Thirdly, further thematic analysis such as mixed-methods approaches to explore HSD drivers, including qualitative interviews with healthcare providers and spatial analyses of diagnostic resource distribution should be employed in future research.
Conclusions
This retrospective study has provided valuable insights into the trends and delays in PTB diagnosis among elderly patients in Guangdong Province over a 13-year period. The key findings include a decrease in TB notification rates among patients aged 60 years and above, juxtaposed with an increasing proportion of elderly TB cases among the newly diagnosed. Although there has been a notable decline in PD, a concerning rise in HSD has been observed. This increase in HSD has effectively counterbalanced the decrease in PD, ultimately leading to a rather stagnant TDD, highlighting the need for urgent attention and improvement within the health system to prevent further stagnation of TDD. Additionally, elderly patients with respiratory comorbidities, especially in underdeveloped areas, face a higher risk of experiencing TDD. These findings underscore the critical need for targeted interventions to enhance the timeliness of TB diagnosis within this vulnerable demographic.
Policy recommendations from this study include enhancing access to healthcare services in underdeveloped areas, bolstering the diagnostic capabilities of local medical facilities, and increasing TB education and awareness campaigns targeted at the elderly. Implementing these measures could significantly reduce diagnostic delays and improve patient outcomes.Future research should focus on conducting longitudinal studies to assess the long-term impact of these policies.
Data availability
According to Chinese law, the surveillance data of TBIMS are not publicly available, but are available on reasonable requests from the corresponding author.
Abbreviations
- TB:
-
Tuberculosis
- PTB:
-
Pulmonary tuberculosis
- TBIMS:
-
Tuberculosis information management system
- PD:
-
Patient delay
- HSD:
-
Health system delay
- TDD:
-
Total diagnostic delay
- HIV/AIDS:
-
Human immunodeficiency virus/Acquired immune deficiency syndrome
- PRDR:
-
Pearl river delta region
- EG:
-
Eastern guangdong
- WG:
-
Western guangdong
- NG:
-
Northern guangdong
- DM:
-
Diabetes mellitus
- IQR:
-
Interquartile ranges
- APC:
-
Annual percent change
- AAPC:
-
Average annual percent change
- CI:
-
Confidence intervals
- cOR:
-
Crude odds ratios
- aOR:
-
Adjusted odds ratios
References
World Health Organization. Global tuberculosis report 2024.
Caraux-Paz P, Diamantis S, de Wazières B, Gallien S. Tuberculosis in the elderly. J Clin Med 2021;10(24).
Cuervo AM, Macian F. Autophagy and the immune function in aging. Curr Opin Immunol. 2014;29:97–104.
Quattrocchi A, Barchitta M, Nobile CGA, Prato R, Sotgiu G, Casuccio A, Vitale F, Agodi A. Determinants of patient and health system delay among Italian and foreign-born patients with pulmonary tuberculosis: a multicentre cross-sectional study. BMJ Open. 2018;8(8):e019673.
Wang X, Li Y, Fu Q, Zhou M. Trends of a decade in risk factors of patient delay among pulmonary tuberculosis patients during fast aging and urbanization - analysis of surveillance data from 2008 to 2017 in Wuhan, China. BMC Public Health. 2023;23(1):803.
Liu K, Xie Z, Xie B, Chen S, Zhang Y, Wang W, Wu Q, Cai G, Chen B. Bridging the gap in end tuberculosis targets in the elderly population in Eastern China: observational study from 2015 to 2020. JMIR Public Health Surveill. 2022;8(7):e39142.
Zhang L, Weng TP, Wang HY, Sun F, Liu YY, Lin K, Zhou Z, Chen YY, Li YG, Chen JW, et al. Patient pathway analysis of tuberculosis diagnostic delay: a multicentre retrospective cohort study in China. Clin Microbiol Infect. 2021;27(7):1000–6.
Mori T, Leung CC. Tuberculosis in the global aging population. Infect Dis Clin North Am. 2010;24(3):751–68.
Liu K, Ge R, Luo D, Zheng Y, Shen Z, Chen B, Feng W, Wu Q. Delay analysis of pulmonary tuberculosis in the Eastern coastal County of China from 2010 to 2021: evidence from two surveillance systems. Front Public Health. 2023;11:1233637.
Zhou FJ, Wu HZ, Li JW, Feng HY, Huang SS, Chen L, Liao QH, Wen WP. Epidemiological characteristics of pulmonary tuberculosis in Guangdong Province from 2016 to 2020. Zhonghua Liu Xing Bing Xue Za Zhi. 2022;43(10):1568–74.
Wang XY, Jiang ML, Pang YJ, Sun DJY, Yu CQ, Wang L, Lyu J, Li LM. Current status of tuberculosis burden in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2024;45(6):857–64.
Zhou FJ, Feng HY, Fang LJ, Chen YH, Wen WP, Liao QH, Wu HZ. Analysis on the trend and influencing factors of detection delay in patients with active tuberculosis in Guangdong Province from 2016 to 2020. Chin J Antituberculosis. 2023;45(01):85–95.
Statistics Bureau of Guangdong Province. Guangdong Statistical Yearbook [http://stats.gd.gov.cn/gdtjnj/content/post_4274608.html]
Li T, Zhang H, Shewade HD, Soe KT, Wang L, Du X. Patient and health system delays before registration among migrant patients with tuberculosis who were transferred out in China. BMC Health Serv Res. 2018;18(1):786.
World Health Organization. Diagnostic and Treatment Delay in Tuberculosis. In.; 2006.
Datiko DG, Jerene D, Suarez P. Patient and health system delay among TB patients in Ethiopia: nationwide mixed method cross-sectional study. BMC Public Health. 2020;20(1):1126.
Chimbatata NBW, Zhou C, Chimbatata CM, Mhango L, Diwan VK, Xu B. Barriers to prompt TB diagnosis-a comparative study between Northern Malawi and Eastern rural China. Trans R Soc Trop Med Hyg. 2017;111(11):504–11.
Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.
World Health Organization. China country assessment report on ageing and health [https://www.who.int/publications/i/item/9789241509312]
Cheng J, Sun YN, Zhang CY, Yu YL, Tang LH, Peng H, Peng Y, Yao YX, Hou SY, Li JW, et al. Incidence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study. Infect Dis Poverty. 2020;9(1):13.
van Arkel C, Storms I, Kurver L, Smeenk F, Wielders P, Hoefsloot W, Carpaij N, Boeree MJ, van Crevel R, van Laarhoven A, et al. Elderly patients with tuberculosis in a low-incidence country - Clinical characteristics, inflammation and outcome. J Infect. 2024;89(2):106200.
LoBue PA, Mermin JH. Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA. Lancet Infect Dis. 2017;17(10):e327–33.
Wang LX, Cheng SM, Chen MT, Zhao YL, Zhang H, Jiang SW. The fifth National tuberculosis epidemiological survey in 2010. Chin J Antituberc. 2012;34(8):485–508.
Deo S, Singh S, Jha N, Arinaminpathy N, Dewan P. Predicting the impact of patient and private provider behavior on diagnostic delay for pulmonary tuberculosis patients in India: A simulation modeling study. PLoS Med. 2020;17(5):e1003039.
Li T, Du X, Kang J, Luo D, Liu X, Zhao Y. Patient, diagnosis, and treatment delays among tuberculosis patients before and during COVID-19 Epidemic - China, 2018–2022. China CDC Wkly. 2023;5(12):259–65.
Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377(9776):1495–505.
Mor Z, Kolb H, Lidji M, Migliori G, Leventhal A. Tuberculosis diagnostic delay and therapy outcomes of non-national migrants in Tel Aviv, 1998–2008. Euro Surveill 2013;18(12):20433.
Di Gennaro F, Vittozzi P, Gualano G, Musso M, Mosti S, Mencarini P, Pareo C, Di Caro A, Schininà V, Girardi E et al. Active pulmonary tuberculosis in elderly patients: A 2016–2019 retrospective analysis from an Italian referral hospital. Antibiot (Basel) 2020;9(8):489.
Dale KD, Tay EL, Trauer JM, Trevan PG, Denholm JT. Comparing tuberculosis management under public and private healthcare providers: Victoria, Australia, 2002–2015. BMC Infect Dis. 2017;17(1):324.
Islam MZ, Efa SS, Farjana S. Patient factors related to pre-treatment delay of pulmonary tuberculosis: A retrospective cohort study in Bangladesh. Indian J Tuberc. 2020;67(4):472–8.
Lee CH, Wang JY, Lin HC, Lin PY, Chang JH, Suk CW, Lee LN, Lan CC, Bai KJ. Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: a retrospective nationwide cohort study. BMC Infect Dis. 2017;17(1):449.
Acknowledgements
This study was supported to Fangjing Zhou by Guangdong Province Medical Research Foundation (A2023466) and to Yuhui Chen by Infectious Disease Prevention and Control of the National Science and Technique Major Project(2018ZX10715004-002). The funding had no role in the study design, data collection, analysis, interpretation, or in the writing and submission of this report. The authors were solely responsible for writing the manuscript. No funding was received from any pharmaceutical company or other agency for this work. We would like to thank all the designated TB care facilities in Guangdong Province for confirming the availability of PTB cases, which enabled our detailed analyses.
Funding
This study was supported by Guangdong Province Medical Research Foundation (A2023466) and the Infectious Disease Prevention and Control of the National Science and Technique Major Project (2018ZX10715004-002).
Author information
Authors and Affiliations
Contributions
Fangjing Zhou designed the study, conducted the statistical analyses and drafted the manuscript. Huiying Feng edited the paper, providing insightful comments on the study design. Qi Sun provided laboratory consultation and implemented the statistical analyses. ShanShan Huang, Jianwei Li, and Yuhui Chen validated the PTB notification data. Huiying Feng and Fangjing Zhou contributed significantly to interpreting the results and provided comments to enhance the paper. Huiying Feng and Yuhui Chen are co-corresponding authors, confirming that all listed authors meet the authorship criteria and that no other individuals meeting the criteria have been omitted. The corresponding author confirms that all authors had full access to the study data and accept responsibility for the decision to submit the manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
All materials used in this study strictly adhered to the Declaration of Helsinki and followed the Law of the Prevention and Treatment of Infectious Diseases in the People’s Republic of China.
Informed consent
This study was approved by the ethics committee of the Center for Tuberculosis Control of Guangdong Province (Approve number: GDTBPJ20220008). Only PTB surveillance data was used for analysis with anonymous prior and informed consent was waived.
Consent for publication
Not Applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Zhou, F., Sun, Q., Huang, S. et al. Trends and delays in pulmonary tuberculosis diagnosis among elderly patients (≥ 60 Years) in Southern China: a 13-year surveillance data analysis (2010–2022). BMC Public Health 25, 1854 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12889-025-23031-5
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12889-025-23031-5